• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

WellTheory Launches Women’s Health Program to Address Autoimmune and Hormonal Conditions

by Jasmine Pennic 12/17/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– WellTheory, a virtual care platform specializing in autoimmune disease management, has announced the launch of a new program specifically designed for women’s health. 

– The Women’s Health program focuses on the interconnectedness of autoimmune diseases and hormonal imbalances, offering comprehensive support and treatment to improve women’s overall well-being.

Addressing the Unique Needs of Women with Autoimmune Diseases

Autoimmune diseases disproportionately affect women, with 80% of those diagnosed being female. Hormonal fluctuations throughout a woman’s life, such as during puberty, pregnancy, and menopause, can significantly influence the development and progression of these conditions.

WellTheory’s women’s health program recognizes this critical link and offers a holistic approach to care, addressing both autoimmune symptoms and hormonal imbalances. The program aims to:

  • Reduce symptoms: Alleviate symptoms commonly associated with hormonal imbalances, such as fatigue, mood swings, and digestive issues.
  • Improve quality of life: Enhance overall well-being and empower women to live full and active lives.
  • Lower healthcare costs: Reduce the need for expensive treatments and medications by addressing the root causes of autoimmune and hormonal conditions.

With the launch of its women’s health program, WellTheory is further demonstrating its commitment to providing personalized and effective care for individuals with autoimmune diseases. 

“As a woman who began suffering with an autoimmune disease in my mid-20’s, who went on to learn that multiple hormonal issues were one of the root causes of my diagnosis, it was important to create a program aimed at helping other women navigate this oftentimes long and frustrating journey to get find solutions,” said Ellen Rudolph, CEO and Co-Founder of WellTheory. “As women’s health remains underfunded and overlooked, WellTheory is dedicated to bringing much needed attention and personalized support to those struggling most and will continue to be at the forefront of working to reverse the autoimmune epidemic — which goes hand in hand with the women’s health crisis.” 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A: Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |